Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -423.76% | -16.34% | 683.02% | -236.66% | 120.76% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 6.67% | 6.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 658.00% | 276.95% | 42.89% | 187.96% | 38.27% |
| Change in Net Operating Assets | 110.02% | 24,463.64% | -775.62% | 261.89% | -289.36% |
| Cash from Operations | 81.77% | 123.36% | 64.97% | 117.67% | -1,284.00% |
| Capital Expenditure | -- | -- | -- | -- | 67.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.06% | -345.45% | -100.00% | -- | -117.07% |
| Cash from Investing | 0.91% | -345.45% | -100.00% | -- | -85.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.59% | 119.97% | -870.59% | 401.34% | 755.48% |